Noveris Health Sciences Inc. (CSE:NVRS)
2.200
+0.220 (11.11%)
At close: Mar 19, 2026
Noveris Health Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
128.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 7.49K | 4.88K | 186.32% |
| Dec 31, 2020 | 2.62K | -122.96K | -97.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNoveris Health Sciences News
- 15 days ago - Noveris Provides Announces Trading Halt Order, And Clarification As To Article - TheNewswire
- 23 days ago - Noveris Announces Closing of Life Offering - TheNewswire
- 26 days ago - Noveris Health Sciences Inc. Unaware Of Any Material Change - TheNewswire
- 4 weeks ago - Noveris Health Sciences Launches Investor Website and Engages Fairfax Partners Inc. for Investor Relations and Digital Marketing Services - TheNewswire
- 4 weeks ago - Noveris Announces Resignation Of CEO - TheNewswire
- 5 weeks ago - Noveris Announces Conversion Of Debentures; Filing Of Early Warning Reports By JJK Holdings Ltd. And Joshua Bartch - TheNewswire
- 6 weeks ago - JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. - TheNewswire
- 7 weeks ago - Noveris Provides Supplemental Disclosure Regarding Previously Announced Convertible Debenture Issuances - TheNewswire